The role of the THY1 gene in human ovarian cancer suppression based on transfection studies

Cancer Genetics and Cytogenetics

Volumn 149, Issue 1, 2004, Pages 1-10

  Abeysinghe, Harindra R ^a   Pollock, Stephen J ^a   Guckert, Nedra L ^a   Veyberman, Yana ^a   Keng, Peter ^a   Halterman, Marc ^a   Federoff, Howard J ^a   Rosenblatt, Joseph P ^a   Wang, Nancy ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLYCOPROTEIN;

ADULT; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENICITY; CHROMOSOME 11; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DNA SEQUENCE; FEMALE; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC TRANSFECTION; GROWTH RATE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOCYTOCHEMISTRY; IN VIVO STUDY; INOCULATION; MOLECULAR CLONING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; THY1 GENE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

EID: 0842324414     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00234-6     Document Type: Article

References (23)

1. Cao Q., Abeysinghe H.R., Fong C.-T., Keng P., Insel R.A., Barrett J., Wang N. Functional detection of a tumor suppressor gene on chromosome 11 and 17 in the human ovarian carcinoma cell line SKOV-3 using microcell-mediated chromosome transfer. Cancer Genet Cytogenet. 129:2001;131-137.
2. Abeysinghe H.R., Cao Q., Xu J., Pollock S.J., Veyberman Y., Guckert N.L., Keng P., Wang N. THY1 expression is associated with tumor suppression of human ovarian cancer. Cancer Genet Cytogenet. 143:2003;125-132.
3. Boring C.C., Squires T.S., Tong T. Cancer statistics. CA Cancer J Clin. 43:1993;7-26.
4. Borresen A. Oncogenesis in ovarian cancer. Acta Obstet Gynecol Suppl. 155:1992;25-30.
5. Gabra H., Taylor L., Cohen B.B., Lessels A., Eccles D.M., Leonard R.C., Smyth J.F., Steel C.M. Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumors. Br J Cancer. 72:1995;367-375.
6. Gabra H., Watson J.E., Taylor K.J., Mackay J., Leonard R.C., Steel C.M., Porteous D.J., Smyth J.F. Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res. 56:1996;950-954.
7. van Rijs J., Giguere V., Hurst J., van Agthoven T., van Kessel A.G., Goyert S., Grosveld F. Chromosomal localization of the human THY1 gene. Proc Natl Acad Sci USA. 82:1985;5832-5835.
8. Seki T., Spurr N., Obata F., Goyert S., Goodfellow P., Silver J. The human THY1 gene: structure and chromosomal location. Proc Natl Acad Sci USA. 82:1985;6657-6661.
9. Reif A.E., Allen J.M.V. The AKR thymic antigen and its distribution in leukemias and nervous tissue. J Exp Med. 120:1964;413-433.
10. Ades E.W., Zwerner R.K., Acton R.T., Balch C.M. Isolation and partial characterization of the human homologue of THY1. J Exp Med. 151:1980;400-406.
11. Hamann A., Arndt R., Klein P., Thiele H.G. Isolation and characterization of the thymus-brain antigen (analogous to thy-1 antigen) from human brain. Biochem J. 187:1980;403-412.
12. Bonewald L., Ades E.W., Tung E., Marchalonis J.J., Wang A.C. Biochemical characterization of THY1. J Immunogenet. 11:1984;283-296.
13. Crawford J.M., Barton R.W. THY1 glycoprotein: structure, distribution, and ontogeny. Lab Invest. 54:1986;122-135.
14. Gunter K.C., Malek T.R., Shevac E.M. T cell activating properties of an anti-THY1 monoclonal antibody: possible analogy to OKT3/Leu-4. J Exp Med. 159:1984;716-730.
15. MacDonald H.R., Bron C., Rousseaux M., Horvath C., Cerottini J.C. Production and characterization of monoclonal anti-THY1 antibodies that stimulate lymphokine production by cytolytic T cell clones. Eur J Immunol. 15:1985;495-501.
16. Nakashima I., Zhang Y.H., Rahman S.M., Yoshida T., Isobe K., Ding L.N., Iwamoto T., Hamaguchi M., Ikezawa H., Taguchi R. Evidence of synergy between THY1 and CD3/TCR complex in signal delivery to murine thymocytes for cell death. J Immunol. 147:1991;1153-1162.
17. Tentori L., Pardoll D.M., Zuniga J.C., Hu-Li J., Paul W.E., Bluestone J.A., Kruisbeek A.M. Proliferation and production of IL-2 and B cell stimulatory factor I/IL-4 in early fetal thymocytes by activation through THY1 and CD3. J Immunol. 140:1988;1089-1094.
18. Hueber A.O., Raposo G., Pierres M., He H.T. THY1 triggers mouse thymocyte apoptosis through a bcl-2-resistant mechanism. J Exp Med. 179:1994;785-796.
19. Presl J., Bukovsky A. Role of THY1+ and Ia+ cells in ovarian function. Biol Reprod. 34:1986;159-169.
20. Bukovsky A., Keenan J.A., Caudle M.R., Wimalasena J., Upadhyaya N.B., Van Meter S.E. Immunohistochemical studies of the adult human ovary: possible contribution of immune and epithelial factors to folliculogenesis. Am J Reprod Immunol. 33:1995;323-340.
21. Morita H., Isobe K., Cai Z., Miyazaki T., Matsumoto Y., Shinzato T., Yoshikai Y., Kimata K., Maeda K. THY1 antigen mediates apoptosis of rat glomerular cells in vitro and in vivo. Nephron. 73:1996;293-298.
22. Lee W.S., Jain M.K., Arkonac B.M., Zhang D., Shaw S.Y., Kashiki S., Maemura K., Lee S.L., Hollenberg N.K., Lee M.E., Haber E. THY1, a novel marker for angiogenesis upregulated by inflammatory cytokines. Circ Res. 82:1998;845-851.
23. Beissert S., He H.T., Hueber A.O., Lellouch A.C., Metze D., Mehling A., Luger T.A., Schwarz T., Grabbe S. Impaired cutaneous immune responses in THY1-deficient mice. J Immunol. 161:1998;5296-5302.